Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec 24:2020:2582938.
doi: 10.1155/2020/2582938. eCollection 2020.

TAVR: A Review of Current Practices and Considerations in Low-Risk Patients

Jenna Spears  1 , Yousif Al-Saiegh  1 , David Goldberg  2 , Sina Manthey  1 , Sheldon Goldberg  2
Affiliations
Review

TAVR: A Review of Current Practices and Considerations in Low-Risk Patients

Jenna Spears et al. J Interv Cardiol. .

Abstract

Transcatheter aortic valve replacement (TAVR) is an established treatment for severe, symptomatic, aortic stenosis (AS) in patients of all risk categories and now comprises 12.5% of all aortic valve replacements. TAVR is a less invasive alternative to traditional surgical aortic valve replacement (SAVR), with equivalent or superior outcomes. The use of TAVR has increased rapidly. The success and increase in use of TAVR are a result of advances in technology, greater operator experience, and improved outcomes. Indications have recently expanded to include patients considered to be at low risk for SAVR. While TAVR outcomes have improved, remaining challenges include the management of coexistent coronary artery disease, prevention of periprocedural stroke, and issue of durability. These issues are even more relevant for low-risk, younger patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

References

    1. Kourkoveli P., Spargias K., Hahalis G. TAVR in 2017-what we know? what to expect? Journal of Geriatric Cardiology. 2018;15(1):55–60. doi: 10.11909/j.issn.1671-5411.2018.01.005. - DOI - PMC - PubMed
    1. Mack M. J. Two-year clinical and echocardiographic outcomes from the PARTNER 3 low-risk randomized trial. 2020.
    1. Osnabrugge R. L., Mylotte D., Head S. J, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. Journal of the American College of Cardiology. 2013;62(11):1002–1012. doi: 10.1016/j.jacc.2013.05.015. - DOI - PubMed
    1. Joseph J., Naqvi S. Y., Giri J., Goldberg S. Aortic stenosis: pathophysiology, diagnosis, and therapy. The American Journal of Medicine. 2017;130(3):253–263. doi: 10.1016/j.amjmed.2016.10.005. - DOI - PubMed
    1. De Sciscio P., Brubert J., De Sciscio M., Serrani M., Stasiak J., Moggridge G. D. Quantifying the shift toward transcatheter aortic valve replacement in low-risk patients: a meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(6) doi: 10.1161/CIRCOUTCOMES.116.003287.e003287 - DOI - PubMed

MeSH terms